company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1339000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1231000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2570000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2570000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-304000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-304000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2874000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2875000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2875000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2875000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21759309.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21759309.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q3,2009-07-01,2009-09-30,2011-08-01 06:02:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2894000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2222000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5116000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5116000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14142000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,14142000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9026000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,13000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9039000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9039000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9039000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42364791.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48822686.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43000000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:02:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2789000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5711000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3712000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3712000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12212000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,7000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12205000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12205000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12205000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47426991.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47426991.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46900000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,2011-08-01 06:02:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,67000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,67000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,67000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3352000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24641000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27993000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27926000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11080000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11080000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39006000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-2000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39008000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39008000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39008000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60000000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60000000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60412689.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3923000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9125000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13048000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12848000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2115000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2115000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10733000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,9000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10724000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10724000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10724000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67229098.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67229098.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67000000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 17:02:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3742000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10667000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14409000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14209000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,13388000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13388000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-821000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,19000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-802000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-802000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-802000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68104934.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68104934.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,80200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:12:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3967000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21775000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-9125000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16617000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16417000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3160000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3160000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13257000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,13000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13244000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13244000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13244000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65800000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65800000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66003789.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4848000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13985000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18833000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18633000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5811000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5811000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24444000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-26000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24470000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24470000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24470000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,76500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75620130.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4902000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18264000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23166000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22966000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-650000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-650000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23616000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23613000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23613000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23613000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,78700000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,78700000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,78514718.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:01:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5712000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16215000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21927000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21727000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3945000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3945000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17782000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-42000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17824000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17824000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17824000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,78670222.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 16:02:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4061000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34982000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39043000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38843000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8566000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8566000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30277000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,52000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30225000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30225000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30225000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,78800000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,78800000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,78546112.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4671000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19112000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23783000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23583000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10788000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10788000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12795000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12799000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12799000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12799000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85300000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85300000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82906080.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:01:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3721000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14775000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18496000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18296000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-403000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-403000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18699000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,7000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18692000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18692000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18692000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85000000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85000000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83082633.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3068000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6247000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9315000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9115000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7407000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7407000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16522000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-191000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16713000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16713000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16713000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,83600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83161927.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:01:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4201000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2718000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6919000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6719000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1793000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1793000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8512000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-391000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8903000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8903000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8903000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85943175.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3442000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6542000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9984000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9784000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,82000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,82000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9702000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-9000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9711000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9711000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9711000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100229200.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:23:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3031000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8346000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11377000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11177000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5577000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5576000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5576000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5576000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,92900000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,92900000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100422564.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,633000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,633000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,633000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2842000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9733000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12575000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11942000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5847000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5847000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6095000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6093000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6093000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6093000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,101600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100428520.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:02:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,340000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,340000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,340000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2851000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8085000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10936000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10596000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,194000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,194000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10402000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10401000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10401000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10401000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101130710.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,272000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,272000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,272000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4250000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,74249000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78499000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-78227000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-78227000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78231000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78231000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-78231000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113400000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113400000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113410250.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.69
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,272000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,272000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,272000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7073000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7424000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14497000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14225000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14225000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,14000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14211000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14211000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14211000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,129200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,129200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,128413417.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:02:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1869000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1869000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1869000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3065000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16970000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20035000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18166000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18166000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18170000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18170000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18170000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,129800000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,129800000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,129732356.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:02:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1919000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1919000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1919000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3259000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8142000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11401000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9482000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9482000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,6000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9476000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9476000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9476000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,125100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,125416084.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1969000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1969000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1969000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3810000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10199000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14009000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12040000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12040000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,21000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12019000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12019000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12019000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,133500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,133500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130157927.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1697000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1697000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1697000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3711000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,129228000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,132939000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-131242000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-131242000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,42000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-131200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-131200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-131200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,129900000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.01
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,129900000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.01
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130385077.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,2017-07-31 16:02:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.01
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1598000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1598000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1598000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3537000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8975000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12512000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10914000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,21000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,21000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10893000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,39000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10854000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10854000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,3591000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14445000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,131300000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,131300000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130496035.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:02:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3319000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9389000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12708000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11111000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-145000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-145000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11256000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,32000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11224000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11224000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,3532000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14756000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,130391463.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,130391463.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3595000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11967000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15562000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13965000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1560000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1560000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15525000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,38000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15487000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15487000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,4171000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19658000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,131100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,131100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130696400.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3780000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10831000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14611000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13014000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,66000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,66000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12948000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,86000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12862000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12862000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,4865000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17727000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,136400000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,136400000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,135630210.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:03:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1598000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1598000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1598000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3571000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11105000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14676000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13078000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,202000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,202000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12876000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,175000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12701000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12701000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,4903000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17604000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,135400000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,135400000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,140632297.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 08:01:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1597000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3852000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11181000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15033000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13436000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13439000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,166000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13273000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13273000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,4999000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18272000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,136938264.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,136938264.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,138200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,146000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,146000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,146000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6159000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10183000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16342000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16196000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,28000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16168000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,148000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16020000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16020000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,5120000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21140000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,140900000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,140900000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,140853120.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4889000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7489000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12378000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12378000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,183000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,183000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12195000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,164000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12031000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12031000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,5462000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17493000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,145800000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,145800000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,141017898.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:03:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8299000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8299000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7699000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7699000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7699000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7699000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:02:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7699000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8870000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8163000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17033000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17633000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-53000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-53000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17686000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,319000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17367000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17367000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,6416000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-207361000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,183578000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,143508674.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.23
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,143710160.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.23
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,138600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.26
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4145000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9476000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13621000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13621000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13621000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,187000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13434000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13434000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13434000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,167900000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,167900000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,160640859.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8641000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8641000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7541000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7541000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7541000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7541000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:02:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7541000.0
